Lightbox
Commercial- Indications
- Peripheral artery disease, Coronary artery disease
Company intelligence / Profile preview
Avinger has commercialized the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of PAD. Its Pantheris device demonstrated safety and efficacy in the INSIGHT trial for treating in-stent restenosis. The company is developing a new image-guided CTO-crossing system targeting coronary artery disease, with an FDA pre-submission package filed and IDE application planned.[3][6]
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avinger.